... 1 (CS1) seminoma. Patients and Methods: During 2008-2013, 1,050 patients with seminoma CS1 were prospectively registered with regard to assessing management modality (radiotherapy, carboplatin, surveillance). Associations with tumor size, rete testis invasion, age, year of diagnosis, type...

...Tomoaki Terakawa; Hideaki Miyake; Naoki Yokoyama; Akira Miyazaki; Hiroyuki Tanaka; Takaaki Inoue; Masato Fujisawa Objective: The objective was to investigate the efficacy and tolerability of combined therapy with paclitaxel and carboplatin (TC) in patients with advanced urothelial carcinoma after...

...W. Bohle; U. Ruether; J. Rassweiler; C. Nunnensiek; F. Eisenberger; P. Jipp Single-agent carboplatin chemotherapy has recently been introduced into the therapy of limited seminoma. Because of poor compliance due to Down’s syndrome we successfully treated a 32-year-old man with relapsed stage-IIIB...

...Hideki Fuse; Yasuyoshi Fujiuchi; Akira Junicho; Masashi Iwasaki; Takashi Katayama To examine the effect of carboplatin on testicular function, carboplatin was administered to mature male Sprague-Dawley rats. Four weeks after carboplatin treatment, the serum level of follicle-stimulating hormone...